Laura Mazzuti
About
In The Last Decade
Laura Mazzuti
20 papers receiving 406 citations
Peers
Comparison fields: 5 of 68
- Obstetrics and Gynecology 216
- Infectious Diseases 200
- Oncology 135
- Reproductive Medicine 59
- Immunology 42
Countries citing papers authored by Laura Mazzuti
This map shows the geographic impact of Laura Mazzuti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Mazzuti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Mazzuti more than expected).
Fields of papers citing papers by Laura Mazzuti
This network shows the impact of papers produced by Laura Mazzuti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Mazzuti. The network helps show where Laura Mazzuti may publish in the future.
Co-authorship network of co-authors of Laura Mazzuti
This figure shows the co-authorship network connecting the top 25 collaborators of Laura Mazzuti. A scholar is included among the top collaborators of Laura Mazzuti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Mazzuti. Laura Mazzuti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 27 | |
| 2 | 1 | |
| 3 | Convalescent plasma for haematological patients with SARS-CoV-2 pneumonia and severe depletion of B-cell lymphocytes following anti-CD20 therapy: a single-centre experience and review of the literature | 7 |
| 4 | 4 | |
| 5 | 5 | |
| 6 | 3 | |
| 7 | 21 | |
| 8 | 22 | |
| 9 | Chest computed tomography score, cycle threshold values and secondary infection in predicting COVID-19 mortality. | 7 |
| 10 | 15 | |
| 11 | 196 | |
| 12 | 8 | |
| 13 | 9 | |
| 14 | 18 | |
| 15 | 3 | |
| 16 | 2 | |
| 17 | Lack of association of Chlamydia pneumoniae with cardiovascular diseases in virologically suppressed HIV patients. | 1 |
| 18 | Evaluation of performances of VERSANT HCV RNA 1.0 assay (kPCR) and Roche COBAS AmpliPrep/COBAS TaqMan HCV test v2.0 at low level viremia. | 5 |
| 19 | 7 | |
| 20 | Genetic analyses of HIV-1 pol sequences from Zimbabwean patients. | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.